Table 1.
Patient characteristics.
| N = 23 | |
|---|---|
| Age, y | 66.8 ± 9.5 |
| Male | 16 (70) |
| Female | 7 (30) |
| Body mass index, kg/m2 | 27.9 ± 4.3 |
| Follow-up, mos (range) | 12 (8-14) |
| CAD risk factors | |
| Prior tobacco use | 12 (52) |
| Current tobacco use | 5 (22) |
| Diabetes mellitus | 5 (22) |
| Hypertension | 22 (96) |
| Hyperlipidemia | 20 (87) |
| Previous myocardial infarction | 16 (70) |
| Family history of CAD | 11 (48) |
| Medications at index procedure | |
| Aspirin | 23 (100) |
| Calcium channel blocker | 10 (43) |
| Statin | 23 (100) |
| ACE-I/ARB | 22 (96) |
| Beta-blocker | 17 (74) |
| Baseline laboratory data | |
| LDL, mg/dL | 83 ± 32 |
| HDL, mg/dL | 49 ± 16 |
| Total cholesterol, mg/dL | 155 ± 36 |
| Triglycerides, mg/dL | 128 ± 53 |
| Lipoprotein(a), mg/dL | 34 ± 32 |
| hs-CRP, mg/L | 1.3 ± 1.5 |
| MMP-9, ng/mL | 3.7 ± 3.7 |
| 12-Month laboratory data | |
| LDL, mg/dL | 56 ± 15 |
| HDL, mg/dL | 46 ± 10 |
| Total cholesterol, mg/dL | 125 ± 21 |
| Triglycerides, mg/dL | 114 ± 43 |
| Lipoprotein(a), mg/dL | 38 ± 42 |
| hs-CRP, mg/L | 2.4 ± 4.3 |
| MMP-9, ng/mL | 5.2 ± 4.3 |
| Imaged vessel | |
| Left anterior descending artery | 10 (43) |
| Left circumflex artery | 6 (26) |
| Right coronary artery | 7 (30) |
Data are presented as mean ± SD for continuous variables and n (%) for categorical variables. Missing laboratory data were omitted from calculations.
ACE-I/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; CAD, coronary artery disease; HDL, high-density lipoprotein; hs-CRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; MMP-9, matrix metalloproteinase-9.